Intermediate dose methotrexate and sequential L-asparaginase for treatment of refractory acute lymphocytic leukaemia.

Shetty, P A; Kurkure, P A; Dasgupta, A

Shetty, P A; Kurkure, P A; Dasgupta, A.

Indian J Cancer ; 21(1): 45-9, 1984.

Article in En | MEDLINE | ID: mdl-6595214

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Asparaginase/administration & dosage; Leukemia, Lymphoid/drug therapy; Methotrexate/administration & dosage; Adolescent; Adult; Child; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Asparaginase / Leukemia, Lymphoid / Antineoplastic Combined Chemotherapy Protocols / Methotrexate Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Child / Female / Humans / Male Language: En Journal: Indian J Cancer Year: 1984 Document type: Article

Search on Google

Add to My VHL

XML

PubMed Links